Gene Editing to Cure

Strengthening Current methods to treat non-communicable diseases through innovative technologies of genome editing

Challenges

Achieving the Sustainable Development Goal (SDG) target of reducing premature deaths from non-communicable diseases by one-third by 2030 requires innovative and efficient technologies. However, many research institutes in the Global South often lack technical equipment and capacity for the most novel technologies. Although it is now common in non-communicable disease research to correlate disease incidence with expression of a particular gene(s), studies are rarely continued beyond this. Researchers in ICGEB Member Countries need to learn techniques that can drive this research further, to develop animal and cellular models of human diseases, so that development of innovative therapies can become possible also in the laboratories in the South. 

Toward a Solution

Traditional practices and methods used to treat many non-communicable diseases are not sufficient to tackle their increasing burden throughout the world. It is becoming clear that new developments and approaches in health research can offer innovative and efficient solutions to these problems. Through the cooperation and training spearheaded by the ICGEB, innovative therapies and the means to develop them are now becoming available in low-resource settings.  

Gene editing is emerging as one of the key new technologies in this arena. It is a technology that allows the genetic information of mammalian cells to be edited with great precision, thus potentially allowing the correction of mutations linked to human diseases. It is a relatively easy to implement and inexpensive technology that can be implemented in any molecular biology laboratory. 

Since 2016, the ICGEB has been instrumental in creating South-South platforms to share knowledge on the most modern technologies in gene editing and their application in the medical field through the organization of theoretical and practical workshops. The areas covered by these workshops are:  

  • the generation of animal models carrying the mutations associated with human diseases in order to gain insights into the molecular mechanisms responsible for disease onset and progression; 
  • the introduction of these mutations into embryonic stem cells and induced pluripotent stem (iPS) cells in order to create cellular models of the disease and use them to screen for the efficacy of particular drugs, or to understand the inter-individual variability in the manifestations of a disease caused by the same genetic mutation (precision medicine);  
  • the development of innovative therapies based on gene editing. 

This technology can be applied to the development of simple, cost-effective models in such organisms as zebrafish and C. elegans worms, which can be used to study the implications of gene modification in non-communicable diseases. This leads to more impactful science and thus an improved ability to apply for research funding; more importantly, it leads to results that are more likely to be translated into applicable therapeutics. 

These ICGEB international workshops allow scientists from Member States to understand the most recent gene editing procedures and to apply them in their own countries and laboratories. During these workshops, scientists from the ICGEB constituency learn from each other, share technology, start new collaborations, and have the opportunity to discuss the ethical and regulatory issues associated with the technology. One tangible example is the ‘ICGEB – Joint Research Centre (JRC) Workshop on Genome Editing’, which gathered expertise from Belgium, Italy, Kenya, Latvia, Nigeria, Thailand and the United Kingdom, , and strengthened collaboration among various academic institutions and laboratories in an effort to provide consultancy on the regulatory, ethical and societal challenges driven by the technology and its applications. South-South and triangular cooperation are nurtured also via technology transfer and collaborations with the industry in Argentina, Brazil, Egypt, Iran, Lebanon, Syrian Arab Republic, among others.  

International workshops represent a unique opportunity to gain the knowledge necessary to extend the impact of correlation studies on the gene expression, which are increasingly being performed in the Global South, as documented by the numbers of grant applications on this subject that have been received by the ICGEB in the current year.  

The outcome of the practice is ultimately capacity building and knowledge transfer in the Global South, which goes beyond the traditional practices and methods used to treat non-communicable diseases and to the vanguard field of gene editing. 

Being directly linked with the aim of reducing mortality rates of non-communicable diseases, gene editing contributes to improving treatment plans and enriching genetic information about the onset and progression of diseases.   

The sustainability of the practice is ensured both by the spill-over effect of the international workshops as well as the cooperation established between research institutions and researchers. The initiative is scalable and replicable in other countries in the Global South, because the ICGEB has a strong scientific network worldwide, and its Programme management structure has been working effectively for decades. The model of ICGEB’s standard procedures and infrastructure, which have a reputation for neutrality, integrity and transparency, are easily reproduced. 

CONTACT INFORMATION
Ms Marianna Maculan, Chief, External Relations, International Centre for Genetic Engineering and Biotechnology (ICGEB)
SDG
03 - Good Health and Well-being
COUNTRIES INVOLVED
Italy
SUPPORTED BY
ICGEB; Governments of Italy, India, and South Africa; European Union

ABOUT

Terms of Service

Privacy Policy

Disclosures

RESOURCES

Terms of Service

Privacy Policy

Disclosures

ENGAGE

Terms of Service

Privacy Policy

Disclosures

Copyright © UNOSSC/UNDP

wpChatIcon
wpChatIcon

Alliance Application Form

Submit an Expression of Interest and/or Demand Signal. UNOSSC reviews submissions on a rolling basis.

1. Official name of organization / institution / government entity (exclusions to apply) *
2. Country *
3. Region *
4. SDG *
Secondary SDG *
5. Partner category *
6. Website *
7. Brief description of your institution (max. 150 words) *
Name for the Lead *
Title for the Lead *
Email address for the Lead *
Name for the co-lead
Title for the co-lead
Email address for the co-lead
Section 3. Expression of Interest in the Alliance *
Additional information on proposed areas of engagement may be requested through the platform following initial review by the Alliance Secretariat.
Section 4. Due Diligence and Integrity Declaration *

Submission Note:

  • Submission of this Expression of Interest form does not automatically confer participation in the Alliance.
  • All submissions will be reviewed by the Alliance Secretariat, including basic eligibility screening and proportionate due diligence, as appropriate.
  • Participation in Alliance activities is determined based on relevance to articulated cooperation needs, alignment with Alliance principles, and integrity considerations.
  • Engagement under the Alliance is voluntary, non-binding, and facilitative in nature, and does not constitute funding approval, contractual commitment, or institutional membership.
  • The Alliance Secretariat may contact submitting entities for additional information or clarification during the review process.

Submission of Demand Form

Description of Demand

Indicate the type of support or cooperation requested through the Alliance.
Please briefly describe the challenge, gap, or priority. (Max. 300 words)

Thematic and Geographic Focus

Please indicate the main focus areas of your demand:

A. Thematic Areas (select up to three)
B. Geographic Focus (select all that apply)

Proposed Engagement Modalities

Please indicate how you would like to engage through the Alliance (select all that apply):

Expected Outcomes

Please indicate the main results you seek to achieve through this engagement. (Max. 200 words)
Examples:
• Capacity strengthened
• Partnerships established
• Sectoral or regional strategies co-developed
• Solutions piloted
• Knowledge generated
• Policies informed

Timeline and Readiness (if applicable)

1. Expected timeframe for engagement:
2. Current stage:

Additional Information

Please provide any additional information, documents, or links relevant to this submission.
(Max. 200 words or upload link)

Submission of Offer Form

Description of Contribution

Indicate the type of contribution your institution can provide and describe the expertise, resources, or solutions you may offer.
Please briefly describe your proposed contribution. (Max. 300 words)

Thematic and Geographic Focus

Please indicate the main focus areas of your interest:

A. Thematic Areas (select up to three)
B. Geographic Focus (select all that apply)

Proposed Engagement Modalities

Please indicate how you would like to engage through the Alliance (select all that apply):

Expected Outcomes

Please indicate the main results you aim to achieve through this engagement. (Max. 200 words)
Examples:
• Capacity strengthened
• Partnerships established
• Sectoral or regional strategies co-developed
• Solutions piloted
• Knowledge generated
• Policies informed

Timeline and Readiness (if applicable)

1. Expected timeframe for engagement:
2. Current stage:

Additional Information

Please provide any additional information, documents, or links relevant to this submission.
(Max. 200 words or upload link)

Organization Registration

Authentication & Due Diligence This prototype simulates identity verification, due diligence confirmation, and an authentication step before submission. *

First Name *
Last Name *
Email address *
Password *
Confirm Password *
Name of institution / organization *
Country / Region *
Organization Type *
Organization other *
Function / role *
Organization logo *
Maximum file size: 1 GB

Login

Login / email *
Password *
Remember me

Forgot password?

Connect form

Your name *
Email *
Organization / institution *
Job title / role *
Reason for connecting:
Short message

Scroll to Top